SEARCH

SEARCH BY CITATION

References

  • Abdul-Ghani MA, Matsuda M, Balas B & DeFronzo RA (2007). Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test. Diabetes Care 30, 8994.
  • Bachmann OP, Dahl DB, Brechtel K, Machann J, Haap M, Maier T, Loviscach M, Stumvoll M, Claussen CD, Schick F, Haring HU & Jacob S (2001). Effects of intravenous and dietary lipid challenge on intramyocellular lipid content and the relation with insulin sensitivity in humans. Diabetes 50, 25792584.
  • Befroy DE, Petersen KF, Dufour S, Mason GF, de Graaf RA, Rothman DL & Shulman GI (2007). Impaired mitochondrial substrate oxidation in muscle of insulin-resistant offspring of type 2 diabetic patients. Diabetes 56, 13761381.
  • Belfort R, Mandarino L, Kashyap S, Wirfel K, Pratipanawatr T, Berria R, DeFronzo RA & Cusi K (2005). Dose-response effect of elevated plasma free fatty acid on insulin signaling. Diabetes 54, 16401648.
  • Bergman RN, Finegood DT & Kahn SE (2002). The evolution of β-cell dysfunction and insulin resistance in type 2 diabetes. Eur J Clin Invest 32 (Suppl 3), 3545.
  • Bisschop PH, de Metz J, Ackermans MT, Endert E, Pijl H, Kuipers F, Meijer AJ, Sauerwein HP & Romijn JA (2001). Dietary fat content alters insulin-mediated glucose metabolism in healthy men. Am J Clin Nutr 73, 554559.
  • Brehm A, Krssak M, Schmid AI, Nowotny P, Waldhausl W & Roden M (2006). Increased lipid availability impairs insulin-stimulated ATP synthesis in human skeletal muscle. Diabetes 55, 136140.
  • Brøns C, Jensen CB, Storgaard H, Alibegovic A, Jacobsen S, Nilsson E, Astrup A, Quistorff B & Vaag A (2008). Mitochondrial function in skeletal muscle is normal and unrelated to insulin action in young men born with low birth weight. J Clin Endocrinol Metab 93, 38853892.
  • Cerf ME (2007). High fat diet modulation of glucose sensing in the β-cell. Med Sci Monit 13, RA12RA17.
  • Chanseaume E, Malpuech-Brugere C, Patrac V, Bielicki G, Rousset P, Couturier K, Salles J, Renou JP, Boirie Y & Morio B (2006). Diets high in sugar, fat, and energy induce muscle type-specific adaptations in mitochondrial functions in rats. J Nutr 136, 21942200.
  • Chanseaume E, Tardy AL, Salles J, Giraudet C, Rousset P, Tissandier A, Boirie Y & Morio B (2007). Chronological approach of diet-induced alterations in muscle mitochondrial functions in rats. Obesity Res 15, 5059.
  • Clore JN, Helm ST & Blackard WG (1995). Loss of hepatic autoregulation after carbohydrate overfeeding in normal man. J Clin Invest 96, 19671972.
  • Cobelli C, Toffolo GM, Man CD, Campioni M, Denti P, Caumo A, Butler P & Rizza R (2007). Assessment of β-cell function in humans, simultaneously with insulin sensitivity and hepatic extraction, from intravenous and oral glucose tests. Am J Physiol Endocrinol Metab 293, E115.
  • Cornier MA, Bergman BC & Bessesen DH (2006). The effects of short-term overfeeding on insulin action in lean and reduced-obese individuals. Metab Clin Exp 55, 12071214.
  • Cusi K, Kashyap S, Gastaldelli A, Bajaj M & Cersosimo E (2007). Effects on insulin secretion and insulin action of a 48-h reduction of plasma free fatty acids with acipimox in nondiabetic subjects genetically predisposed to type 2 diabetes. Am J Physiol Endocrinol Metab 292, E1775E1781.
  • Defronzo RA (2004). Dysfunctional fat cells, lipotoxicity and type 2 diabetes. Int J Clin Pract 58, 921.
  • Faeh D, Minehira K, Schwarz JM, Periasamy R, Park S & Tappy L (2005). Effect of fructose overfeeding and fish oil administration on hepatic de novo lipogenesis and insulin sensitivity in healthy men. Diabetes 54, 19071913.
  • FAO/WHO/UNU (2007). Human energy requirements. Report of a Joint FAO/WHO/UNU Expert Consultation, Rome, 17–24 October 2001. FAO Food and Nutrition Technical Report Series 1. WHO, Geneva.
  • Fasshauer M & Paschke R (2003). Regulation of adipocytokines and insulin resistance. Diabetologia 46, 15941603.
  • Kashyap S, Belfort R, Gastaldelli A, Pratipanawatr T, Berria R, Pratipanawatr W, Bajaj M, Mandarino L, DeFronzo R & Cusi K (2003). A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes. Diabetes 52, 24612474.
  • Kim JK, Wi JK & Youn JH (1996). Plasma free fatty acids decrease insulin-stimulated skeletal muscle glucose uptake by suppressing glycolysis in conscious rats. Diabetes 45, 446453.
  • Kim SP, Ellmerer M, Van Citters GW & Bergman RN (2003). Primacy of hepatic insulin resistance in the development of the metabolic syndrome induced by an isocaloric moderate-fat diet in the dog. Diabetes 52, 24532460.
  • Kim YB, Iwashita S, Tamura T, Tokuyama K & Suzuki M (1995). Effect of high-fat diet on the gene expression of pancreatic GLUT2 and glucokinase in rats. Biochem Biophys Res Commun 208, 10921098.
  • Kotronen A & Yki-Jarvinen H (2008). Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol 28, 2738.
  • Kraegen EW (1991). Development of muscle insulin resistance after liver insulin resistance in high-fat-fed rats. Diabetes 40, 13971403.
  • Krssak M, Falk Petersen K, Dresner A, DiPietro L, Vogel SM, Rothman DL, Shulman GI & Roden M (1999). Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia 42, 113116.
  • Le Stunff & Bougnères P (1994). Early changes in postprandial insulin secretion, not in insulin sensitivity, characterize juvenile obesity. Diabetes 43, 696702.
  • Miyawaki K, Yamada Y, Ban N, Ihara Y, Tsukiyama K, Zhou H, Fujimoto S, Oku A, Tsuda K, Toyokuni S, Hiai H, Mizunoya W, Fushiki T, Holst JJ, Makino M, Tashita A, Kobara Y, Tsubamoto Y, Jinnouchi T, Jomori T & Seino Y (2002). Inhibition of gastric inhibitory polypeptide signaling prevents obesity. Nat Med 8, 738742.
  • Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E, Ridderstrale M, Laurila E, Houstis N, Daly MJ, Patterson N, Mesirov JP, Golub TR, Tamayo P, Spiegelman B, Lander ES, Hirschhorn JN, Altshuler D & Groop LC (2003). PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34, 267273.
  • Park YW, Chang Y, Sung KC, Ryu S, Sung E & Kim WS (2006). The sequential changes in the fasting plasma glucose levels within normoglycemic range predict type 2 diabetes in healthy, young men. Diabetes Res Clin Pract 73, 329335.
  • Patti ME, Butte AJ, Crunkhorn S, Cusi K, Berria R, Kashyap S, Miyazaki Y, Kohane I, Costello M, Saccone R, Landaker EJ, Goldfine AB, Mun E, DeFronzo R, Finlayson J, Kahn CR & Mandarino LJ (2003). Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc Natl Acad Sci U S A 100, 84668471.
  • Perseghin G, Scifo P, De Cobelli F, Pagliato E, Battezzati A, Arcelloni C, Vanzulli A, Testolin G, Pozza G, Del Maschio A & Luzi L (1999). Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes 48, 16001606.
  • Petersen KF, Dufour S & Shulman GI (2005). Decreased insulin-stimulated ATP synthesis and phosphate transport in muscle of insulin-resistant offspring of type 2 diabetic parents. PLoS Med 2, e233.
  • Petersen KF, Befroy D, Dufour S, Dziura J, Ariyan C, Rothman DL, DiPietro L, Cline GW & Shulman GI (2003). Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 300, 11401142.
  • Petersen KF, Dufour S, Befroy D, Garcia R & Shulman GI (2004). Impaired mitochondrial activity in the insulin resistant offspring of patients with type 2 diabetes. N Engl J Med 350, 664671.
  • Prompers JJ, Jeneson JA, Drost MR, Oomens CC, Strijkers GJ & Nicolay K (2006). Dynamic MRS and MRI of skeletal muscle function and biomechanics. NMR Biomed 19, 927953.
  • Randle PJ (1998). Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years. Diabetes Metab Rev 14, 263283.
  • Reimer MK & Ahren B (2002). Altered β-cell distribution of pdx-1 and GLUT-2 after a short-term challenge with a high-fat diet in C57BL/6J mice. Diabetes 51, S138S143.
  • Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW & Shulman GI (1996). Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 97, 28592865.
  • Schrauwen-Hinderling VB, Kooi ME, Hesselink MK, Moonen-Kornips E, Schaart G, Mustard KJ, Hardie DG, Saris WH, Nicolay K & Schrauwen P (2005). Intramyocellular lipid content and molecular adaptations in response to a 1-week high-fat diet. Obes Res 13, 20882094.
  • Sparks LM, Xie H, Koza RA, Mynatt R, Hulver MW, Bray GA & Smith SR (2005). A high-fat diet coordinately downregulates genes required for mitochondrial oxidative phosphorylation in skeletal muscle. Diabetes 54, 19261933.
  • Vaag A, Alford F, Henriksen FL, Christopher M & Beck-Nielsen H (1995). Multiple defects of both hepatic and peripheral intracellular glucose processing contribute to the hyperglycaemia of NIDDM. Diabetologia 38, 326336.
  • Vaag A, Skøtt P, Damsbo P, Gall MA, Richter EA & Beck-Nielsen H (1991). Effect of the antilipolytic nicotinic acid analogue acipimox on whole-body and skeletal muscle glucose metabolism in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 88, 12821290.
  • Westerbacka J, Lammi K, Hakkinen AM, Rissanen A, Salminen I, Aro A & Yki-Jarvinen H (2005). Dietary fat content modifies liver fat in overweight nondiabetic subjects. J Clin Endocrinol Metab 90, 28042809.
  • Wren AM & Bloom SR (2007). Gut hormones and appetite control. Gastroenterology 132, 21162130.